Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Axel Wein"'
Autor:
Jakob Jäger, Maximilian Sprügel, Tamara Brunner, Martin Uhl, Stefan Schwab, Francesco Vitali, Axel Wein, Bastian Volbers
Publikováno v:
Case Reports in Neurology, Vol 14, Iss 3, Pp 475-482 (2022)
Cetuximab is a chimeric IgG1 monoclonal antibody against epidermal growth factor receptor. It is approved by the European medical agency for the treatment of RAS wild-type metastatic colorectal cancer and metastatic squamous cell cancer of the head a
Externí odkaz:
https://doaj.org/article/4baa6ba2484540efad7715e0ef5da89f
Autor:
Axel Wein, Jürgen Siebler, Ruediger Goertz, Kerstin Wolff, Nicola Ostermeier, Dagmar Busse, Andreas E. Kremer, Franz Koch, Alexander Hagel, Michael Farnbacher, Ferdinand J. Kammerer, Markus F. Neurath, Robert Gruetzmann
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 2, Pp 379-386 (2016)
Introduction: The prognostic outcome following progression after palliative first-line treatment for patients suffering from metastatic colorectal adenocarcinoma is generally poor. Long-term relapse-free survival with palliative second-line treatment
Externí odkaz:
https://doaj.org/article/bf8237f8eb6747208b5649fde6a96872
Autor:
Sandra Roehrig, Axel Wein, Heinz Albrecht, Gudrun Maennlein, Kerstin Wolff, Dane Muskoski, Kerstin Amann, Rolf Janka, Werner Hohenberger, Eckhart G. Hahn, Jürgen Siebler, Markus F. Neurath, Frank Boxberger
Publikováno v:
Case Reports in Oncology, Vol 4, Iss 2, Pp 413-419 (2011)
Introduction: The prognostic outlook for patients suffering from pancreatic cancer is generally poor. Particularly in cases of advanced and metastatic disease, long-term relapse-free survival may be achieved only in a few cases. Case Report: A 45-yea
Externí odkaz:
https://doaj.org/article/9473d200eb2e4732a0a7772ab370636a
Autor:
Lukas Pfeifer, Abbas Agaimy, Rolf Janka, Frank Boxberger, Axel Wein, Markus F. Neurath, Jürgen Siebler
Publikováno v:
Case Reports in Oncology, Vol 4, Iss 2, Pp 304-310 (2011)
Inflammatory pseudotumors (IPT) form a group of etiologically, histologically, and biologically heterogeneous tumefactive lesions that are histologically characterized by prominent inflammatory infiltrates. IPT has been described in various organs in
Externí odkaz:
https://doaj.org/article/7da6bfb09f7a40d497197e99c30e22f0
Autor:
Dane Wildner, Frank Boxberger, Axel Wein, Kerstin Wolff, Heinz Albrecht, Gudrun Männlein, Rolf Janka, Kerstin Amann, Jürgen Siebler, Werner Hohenberger, Markus F. Neurath, Richard Strauß
Publikováno v:
Case Reports in Oncological Medicine, Vol 2013 (2013)
Combined chemotherapeutic regimens in conjunction with oxaliplatin are considered safe and effective treatment options in the clinical management of metastatic colorectal cancer. A 62-year-old male patient with a metastatic rectal carcinoma developed
Externí odkaz:
https://doaj.org/article/bb72757126bd406fa3ec7c29e4f21b62
Autor:
Jan-Peter Roth, Francesco Vitali, Dagmar Busse, W Schreiner, Susanne Merkel, Robert Stoehr, Arndt Hartmann, Markus Eckstein, Axel Wein, Stephan Kersting, Michael Uder, Peter Anhut, Robert Grützmann, Jürgen Siebler, Nicola Ostermeier, Markus F. Neurath, Kerstin Wolff, Clemens Neufert
Publikováno v:
Oncology. 100:1-11
Objective: The study aimed to prospectively evaluate a new molecular biomarker panel (KRAS, NRAS, BRAF, PIK3CA, and ERBB2) for palliative first-line treatment of colorectal cancer (CRC), including a multidisciplinary treatment approach. The rate of s
Autor:
Francesco Vitali, Axel Wein, Timo Rath, Markus Eckstein, Clemens Neufert, Jürgen Siebler, Raja Atreya, Arndt Hartmann, Werner Hohenberger, Klaus Weber, Markus Friedrich Neurath, Robert Grützmann, Susanne Merkel
Publikováno v:
International Journal of Colorectal Disease
Purpose Patients with inflammatory bowel disease (IBD) have an increased risk for colorectal cancer (CRC). In IBD patients, cancer is often diagnosed in advanced stages and conflicting data on survival compared to sporadic CRC have been reported. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96c533e7a7882bc9bc3f0183883f9e9e
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/22107
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/22107
Autor:
Axel Wein, Juergen Siebler, Dagmar Busse, Markus F. Neurath, Kirsten Merx, Kerstin Wolff, Nicola Ostermeier, Franz Koch, Alexander F. Hagel, Ralf-Dieter Hofheinz
Publikováno v:
Anticancer research. 37(7)
Background/aim The aim of this work was to evaluate the efficacy and safety of second-line treatment with weekly high-dose 5-fluorouracil (5-FU) as a 24-hour infusion (24-h inf.) combined with sodium folinic acid (FA) (AIO-regimen) plus irinotecan (I
Autor:
Claus Schildberg, Werner Hohenberger, Melanie Langheinrich, Frank Boxberger, Markus F. Neurath, Thomas Weidinger, Axel Wein
Publikováno v:
World Journal of Surgery. 38:419-425
Gastric cancer is one of the most common cancers. Unfortunately, it is often diagnosed at the advanced stage International Union Against Cancer stage IV. This induced us to carry out an interdisciplinary analysis of this patient group with the Depart
Autor:
Jürgen Siebler, Markus F. Neurath, Frank Boxberger, Hanns-Detlev Harich, Frank Dörje, Axel Wein, Werner Hohenberger, Sonja Koch
Publikováno v:
Supportive Care in Cancer. 21:2395-2402
This study aims to evaluate adherence to guidelines of antiemetic prophylaxis and frequency of chemotherapy-induced nausea and vomiting (CINV) in the palliative first-line treatment of colorectal cancer (CRC) patients in Northern Bavaria.We collected